Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease

Journal of Neuro-Oncology

Volumn 110, Issue 2, 2012, Pages 251-256

  Delios, Anna Maria ^a   Rosenblum, Marc ^a   Jakubowski, Ann A ^a   Deangelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute demyelinating encephalomyelitis; Acute inflammatory demyelinating polyradiculopathy; Allogeneic; Demyelinating; Stem cell transplant

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; EPHEDRINE; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MELPHALAN; PYRIDOSTIGMINE; RITUXIMAB; STEROID; THIOTEPA;

ACUTE DEMYELINATING ENCEPHALOMYELITIS; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE INFLAMMATORY DEMYELINATING POLYRADICULOPATHY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; BONE MARROW; BRAIN BIOPSY; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHIMERA; CLINICAL ARTICLE; CONVALESCENCE; DEMYELINATING DISEASE; DEMYELINATION; DRUG MEGADOSE; DRUG RESPONSE; ENCEPHALOMYELITIS; EX VIVO STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; IMMUNE MEDIATED DEMYELINATING DISEASE; IMMUNOPATHOLOGY; IN VIVO STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUROLOGIC DISEASE; PATIENT IDENTIFICATION; PERIPHERAL BLOOD STEM CELL; PERIPHERAL NEUROPATHY; RADICULOPATHY; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SPINAL CORD BIOPSY; T CELL DEPLETION; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84867874148     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0962-9     Document Type: Article

References (20)

1. Brabander C, Cornelissen J, Sillevis Smitt PAE, Vecht ChJ, Van den Bent MJ (2000) Increased incidence of neurological complications in patients receiving allogeneic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 68:36-40
2. Barba P, Pinana JL, Valcarcel D et al (2009) Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation. Biol Blood Marrow Transpl 15:1439-1446
3. Siegal D, Keller A, Xu W et al (2007) Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transpl 13:1369-1379
4. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb L, Straube A (2003) Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60:842-848
5. Weber C, Schaper J, Tibussek D et al (2008) Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation. Bone Marrow Transpl 41:253-259
6. Padovan CS, Gerbitz A, Sostak P et al (2001) Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology 56:1106-1108
7. Grauer O, Wolff D, Bertz H et al (2010) Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease. Brain 133:2852-2865
8. Sakai M, Ohashi K, Ohta K, Yamashita T, Akiyama H, Kisida S et al (2006) Immune-mediated myelopathy following allogeneic stem cell transplantation. Int J Hematol 84:272-275
9. Openshaw H, Slatkin NE, Parker PM, Forman SJ (1995) Immune mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transpl 15(4):633-636
10. Vosz M, Bischof F (2010) Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases. BMC Neurol 10(1):76
11. Matsuo Y, Kamezaki K, Takesihi S, Takenaka K, Eto T, Nonami A et al (2009) Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus host disease after allogeneic bone marrow transplantation. Intern Med 48:1453-1456
12. Bulsara KR, Baron PW, Tuttle-Newhall JE, Clavien PA, Morgenlander J (2001) Guillain-Barre syndrome in organ and bone marrow transplant patients. Transplantation 71:1169-1172
13. Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA (2002) Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl 29:515-517
14. Mohrmann R, Mah V, Vinters H (1990) Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 21(6):630-639
15. Saad AG, Alyea EP III, Wen PY, Degirolami U, Kesari S (2009) Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation. J Clin Oncol 27:e147-e149
16. King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T-cells during immune deficiency generates autoimmunity. Cell 117:265-277
17. Daikeler T, Labopin M, Gioia Di et al (2011) Secondary autoimmune disease occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT autoimmune disease working party. Blood 118:1693-1698
18. Sykes M, Nikolic B (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435:620-627
19. El-Sabrout RA, Radovancevic B, Ankoma-Sey V, Van Buren CT (2001) Guillain-Barre syndrome after solid transplantation. Transplantation 71:1311-1316
20. Roskrow MA, Kelsey SM, McCarthy M, Newland AC, Monson JP (1992) Selective automatic neuropathy as a novel complication of BMT. Bone Marrow Transpl 10(5):469-470